MNTL Tema Neuroscience and Mental Health ETF

21

NASDAQ | ETF

Price
$22.19
Increased by 0.00%
Dollar volume (20D)
3.24 K
ADR%
0.17
Healthcare - 100.00%Basic Materials - 0.00%Communication Services - 0.00%Consumer Cyclicals - 0.00%Consumer Defensive - 0.00%Energy - 0.00%Financial Services - 0.00%Industrials - 0.00%Real Estate - 0.00%Technology - 0.00%Utilities - 0.00%
Healthcare - 100.00%
Basic Materials - 0.00%
Communication Services - 0.00%
Consumer Cyclicals - 0.00%
Consumer Defensive - 0.00%
Energy - 0.00%
Financial Services - 0.00%
Industrials - 0.00%
Real Estate - 0.00%
Technology - 0.00%
Utilities - 0.00%

Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies.

A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health.

The fund is non-diversified.

Top 20 Holdings

Asset Name Sector Industry Weight
VRTX Vertex Pharmaceuticals Inc Healthcare Biotechnology 10.48%
REGN Regeneron Pharmaceuticals Inc Healthcare Biotechnology 7.77%
ALNY Alnylam Pharmaceuticals Inc Healthcare Biotechnology 6.29%
NBIX Neurocrine Biosciences Inc Healthcare Drug Manufacturers - Specialty & Generic 5.05%
TEVA Teva Pharma Industries Ltd ADR Healthcare Drug Manufacturers - Specialty & Generic 5.01%
ARGX argenx NV ADR Healthcare Biotechnology 4.87%
LLY Eli Lilly and Company Healthcare Drug Manufacturers - General 4.37%
CRNX Crinetics Pharmaceuticals Inc Healthcare Biotechnology 4.05%
SYK Stryker Corporation Healthcare Medical Devices 3.33%
BIIB Biogen Inc Healthcare Drug Manufacturers - General 3.22%
IONS Ionis Pharmaceuticals Inc Healthcare Biotechnology 3.13%
CPRX Catalyst Pharmaceuticals Inc Healthcare Biotechnology 2.63%
MDT Medtronic PLC Healthcare Medical Devices 2.59%
ITCI Intracellular Th Healthcare Drug Manufacturers - Specialty & Generic 2.57%
ACAD ACADIA Pharmaceuticals Inc Healthcare Biotechnology 2.47%
AXSM Axsome Therapeutics Inc Healthcare Biotechnology 2.43%
DNLI Denali Therapeutics Inc Healthcare Biotechnology 2.17%
UCB UCB SA Healthcare Biotechnology 2.16%
XENE Xenon Pharmaceuticals Inc Healthcare Biotechnology 1.98%
JAZZ Jazz Pharmaceuticals PLC Healthcare Biotechnology 1.84%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY